The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Autoreactive CD8+ T cells are restrained by an exhaustion-like program that is maintained by LAG3
Open accessAbstract
Impaired chronic viral and tumor clearance has been attributed to CD8+ T cell exhaustion, a differentiation state in which T cells have reduced and altered effector function that can be partially reversed upon blockade of inhibitory receptors. The role of the exhaustion program and transcriptional networks that control CD8+ T cell function and fate in autoimmunity is not clear. Here we show that intra-islet CD8+ T cells phenotypically, transcriptionally, epigenetically and metabolically possess features of canonically exhausted T cells, yet maintain important differences. This 'restrained' phenotype can be perturbed and disease accelerated by CD8+ T cell-restricted deletion of the inhibitory receptor lymphocyte activating gene 3 (LAG3). Mechanistically, LAG3-deficient CD8+ T cells have enhanced effector-like functions, trafficking to the islets, and have a diminished exhausted phenotype, highlighting a physiological role for an exhaustion program in limiting autoimmunity and implicating LAG3 as a target for autoimmune therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“T cell exhaustion may play a role in AIDs, 33-35 and exhausted autoantigen-specific CD8 + T cells were detected in murine and human type 1 diabetes (T1D). 35,36”
From Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases (2024) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and exhausted CD8 and CD4 T cells are present in inflamed tissues of T1D 36,62 and systemic lupus erythematosus (SLE) 63 models.”
From Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases (2024) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., et al. (2019) · Journal of Open Source Software · doi:10.21105/joss.01686 · Cited by 22,138
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Cited by
Sorted by citations
Baessler, A., & Vignali, D. A. A. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090222-110914 · Cited by 420
Self-citationLAG-3 as the third checkpoint inhibitor
Aggarwal, V., Workman, C. J., & Vignali, D. A. A. (2023) · Nature Immunology · doi:10.1038/s41590-023-01569-z · Cited by 344
Self-citationLAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation
Joller, N., Anderson, A. C., & Kuchroo, V. K. (2024) · Immunity · doi:10.1016/j.immuni.2024.01.010 · Cited by 296
Cillo, A. R., Cardello, C., Shan, F., Karapetyan, L., Kunning, S. R., Sander, C., Rush, E. A., Karunamurthy, A. D., Massa, R. C., Rohatgi, A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.036 · Cited by 192
Self-citationRegulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential
Wang, L., Liang, Y., Zhao, C., Ma, P., Zeng, S., Ju, D., Zhao, M., Yu, M., & Shi, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02326-4 · Cited by 190
Ngiow, S. F., Manne, S., Huang, Y., Azar, T., Chen, Z., Mathew, D., Chen, Q., Khan, O., Wu, J. E., Alcalde, V., et al. (2024) · Cell · doi:10.1016/j.cell.2024.07.018 · Cited by 116
Self-citationNovel strategies for cancer immunotherapy: counter-immunoediting therapy
Liu, S., Sun, Q., & Ren, X. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01430-8 · Cited by 107
Regulators of CD8+ T cell exhaustion
Sun, Q., & Dong, C. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01221-x · Cited by 91
Saggau, C., Bacher, P., Esser, D., Rasa, M., Meise, S., Mohr, N., Kohlstedt, N., Hutloff, A., Schacht, S.-S., Dargvainiene, J., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.08.005 · Cited by 79
The immune checkpoint receptor LAG3: Structure, function, and target for cancer immunotherapy
Mariuzza, R. A., Shahid, S., & Karade, S. S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107241 · Cited by 72
Immune checkpoint receptors in autoimmunity
Burke, K. P., Patterson, D. G., Liang, D., & Sharpe, A. H. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2023.102283 · Cited by 70
Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion
Wu, Y., Wu, Y., Gao, Z., Yu, W., Zhang, L., & Zhou, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02327-3 · Cited by 78
Minnie, S. A., Waltner, O. G., Zhang, P., Takahashi, S., Nemychenkov, N. S., Ensbey, K. S., Schmidt, C. R., Legg, S. R. W., Comstock, M., Boiko, J. R., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adg1094 · Cited by 58
T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
Chi, X., Luo, S., Ye, P., Hwang, W., Cha, J., Yan, X., & Yang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1104771 · Cited by 62
The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders
Terrabuio, E., Zenaro, E., & Constantin, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1233870 · Cited by 51
Srivastava, N., Hu, H., Peterson, O. J., Vomund, A. N., Stremska, M. E., Zaman, M., Giri, S., Li, T., Lichti, C. F., Zakharov, P. N., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.04.017 · Cited by 50
Inflammation versus regulation: how interferon-gamma contributes to type 1 diabetes pathogenesis
George, D. J. D., Ge, T., Krishnamurthy, B., Kay, T. W. H., & Thomas, H. E. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1205590 · Cited by 44
Stem-like T cells are associated with the pathogenesis of ulcerative colitis in humans
Li, Y., Ramírez-Suástegui, C., Harris, R. J., Castañeda-Castro, F. E., Ascui, G., Pérez-Jeldres, T., Diaz, A., Morong, C., Giles, D. A., Chai, J. N., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01860-7 · Cited by 39
Advancing beyond the twists and turns of T cell exhaustion in cancer
van der Heide, V., Humblin, É., Vaidya, A. B., & Kamphorst, A. O. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo4997 · Cited by 41
Advances in LAG3 cancer immunotherapeutics
Adam, K. R., Butler, S. C., Workman, C. J., & Vignali, D. A. A. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.10.009 · Cited by 37
Self-citationLin, Y.-H., Chen, C.-W., Chen, M.-Y., Xu, L., Tian, X., Cheung, S.-H., Wu, Y.-C., Siriwon, N., Wu, S., & Mou, K. Y. (2025) · ACS Nano · doi:10.1021/acsnano.5c02541 · Cited by 35
Collier, J. L., Pauken, K. E., Lee, C. A. A., Patterson, D. G., Markson, S. C., Conway, T. S., Fung, M. E., France, J. A., Mucciarone, K., Lian, C. G., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221920 · Cited by 33
Self-citationWang, L., Zhou, H., Chen, Q., Lin, Z., Jiang, C., Chen, X., Chen, M., Liu, L., Shao, L., Liu, X., et al. (2023) · Advanced Science · doi:10.1002/advs.202307858 · Cited by 31
Wen, N., Lu, Y., Zhuo, Y., Fu, B., Wang, H., He, Y., Wu, H., Wang, Z., Tan, W., & Qiu, L. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c18455 · Cited by 30
Heubeck, A. T., Savage, A. K., Henderson, K., Roll, C. R., Hernandez, V., Torgerson, T. R., Bumol, T. F., & Reading, J. (2022) · Cytometry Part A · doi:10.1002/cyto.a.24715 · Cited by 29
Aljobaily, N. A., Allard, D., Perkins, B., Raugh, A., Galland, T., Jing, Y., Stephens, W. Z., Bettini, M. L., Hale, J. S., & Bettini, M. (2024) · Immunity · doi:10.1016/j.immuni.2024.09.016 · Cited by 30
Zhu, Q., Balasubramanian, A., Asirvatham, J. R., Chatterjee, M., Piyarathna, B., Kaur, J. S., Mohamed, N., Wu, L., Wang, S., Pourfarrokh, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61034-3 · Cited by 30
De novo identification of CD4+ T cell epitopes
Zdinak, P. M., Trivedi, N., Grebinoski, S., Torrey, J., Martinez, E. Z., Martínez, S., Hicks, L., Ranjan, R., Makani, V. K. K., Roland, M. M., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02255-0 · Cited by 26
Self-citationEnhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targeting
Cerella, C., Dicato, M. A., & Diederich, M. F. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106914 · Cited by 24
de Cevins, C., Delage, L., Batignes, M., Riller, Q., Luka, M., Rémaury, A., Sorin, B., Fali, T., Masson, C., Hoareau‐Coudert, B., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101333 · Cited by 21
Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example
Lichti, C. F., & Wan, X. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101730 · Cited by 21
New insights into the stemness of adoptively transferred T cells by γc family cytokines
Luo, M., Gong, W., Zhang, Y., Li, H., Ma, D., Wu, K., Gao, Q., & Fang, Y. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01354-3 · Cited by 21
Xia, Z., Lü, C., Pan, C., Li, J., Li, J., Mao, Y., Sun, L., & Jiang, H. (2023) · BMC Medicine · doi:10.1186/s12916-023-02960-1 · Cited by 19
Role of hypoxia-inducible factor 1 in type 1 diabetes
Fagundes, R. R., Zaldumbide, A., & Taylor, C. T. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.07.001 · Cited by 20
CXCR5+CD8 T cells: Potential immunotherapy targets or drivers of immune-mediated adverse events?
Turner, C. N., Mullins, G. N., & Hoyer, K. K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1034764 · Cited by 16
Epitope-based precision immunotherapy of Type 1 diabetes
Firdessa-Fite, R., Genzano, C. B., Mallone, R., & Creusot, R. J. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2154098 · Cited by 15
Papadimitriou, T. I., Singh, P., van Caam, A., Walgreen, B., Gorris, M. A. J., Vitters, E. L., van Ingen, I. L., Koenders, M. I., Smeets, R. L., Vonk, M. C., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224827 · Cited by 16
TIGIT acts as an immune checkpoint upon inhibition of PD1 signaling in autoimmune diabetes
Trivedi, P., Jhala, G., George, D. J. D., Chiu, C. Y. H., Selck, C., Ge, T., Catterall, T., Elkerbout, L., Boon, L., Joller, N., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1370907 · Cited by 17
Wei, X., Jin, C., Li, D., Wang, Y., Zheng, S., Feng, Q., shi, N., Kong, W., Ma, X., & Wang, J. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.06.008 · Cited by 17
Arnold, F., Kupferschmid, L., Weissenborn, P., Heldmann, L., Hummel, J. F., Zareba, P., Sagar, Rogg, M., Schell, C., & Tanriver, Y. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01197-z · Cited by 15
Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells
Dvořáková, T., Finisguerra, V., Formenti, M., Loriot, A. E., Boudhan, L., Zhu, J., & den Eynde, B. J. V. (2024) · Nature Communications · doi:10.1038/s41467-024-51782-z · Cited by 17
Grebinoski, S., Pieklo, G. P., Zhang, Q., Visperas, A., Cui, J., Goulet, J., Xiao, H., Brunazzi, E. A., Cardello, C., Herrada, A. A., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300216 · Cited by 13
Self-citationLAG ‐3—An incompletely understood target in cancer therapy
Leitner, J. M., Radakovics, K., & Steinberger, P. (2024) · The FASEB Journal · doi:10.1096/fj.202401639r · Cited by 12
Oligodendrocyte-derived IL-33 regulates self-reactive CD8+ T cells in CNS autoimmunity
Fonta, N., Pagé, N., Klimek, B., Piccinno, M., Liberto, G. D., Lemeille, S., Kreutzfeldt, M., Kastner, A. L., Ertuna, Y. I., Vincenti, I., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241188 · Cited by 13
Application and Expectations for Immune Checkpoint Blockade of LAG3 and TIGIT
Dumbrava, E. E. I., Frej, K. B. H., Sharon, E., & Tawbi, H. A.-H. (2024) · Annual Review of Medicine · doi:10.1146/annurev-med-080222-100847 · Cited by 11
Monitoring immunomodulation strategies in type 1 diabetes
Krishnamurthy, B., Lacorcia, M., Kay, T. W. H., Thomas, H. E., & Mannering, S. I. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1206874 · Cited by 12
Aberrant CD8+T cells drive reproductive dysfunction in female mice with elevated IFN-γ levels
Bafor, E. E., Erwin-Cohen, R. A., Martin, T., Baker, C., Kimmel, A. E., Duverger, O., Fenimore, J. M., Ramba, M., Spindel, T., Hess, M. M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1368572 · Cited by 10
Selck, C., Jhala, G., George, D. J. D., Kwong, C.-T. J., Christensen, M. K., Pappas, E. G., Liu, X., Ge, T., Trivedi, P., Kallies, A., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315419121 · Cited by 10
Feng, P., Liu, S., Yuan, G., & Pan, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34119 · Cited by 9
Tang, M., Qaiyum, Z., Lim, M., & Inman, R. D. (2025) · iScience · doi:10.1016/j.isci.2025.112715 · Cited by 10
Regulation and Immunotherapeutic Targeting of the Epigenome in Exhausted CD8 T Cell Responses
Ford, B. R., & Poholek, A. C. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200681 · Cited by 9
Pandey, S., Anang, V., & Schumacher, M. M. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.07.003 · Cited by 8
LAG3 Marks Activated but Hyporesponsive NK Cells
Vasilyeva, V., Makinson, O., Chan, C. S. Y., Park, M., O’Dwyer, C., Ali, A., Khan, A. U. H., de Souza, C. T., Hasim, M. S., Asif, S., et al. (2025) · European Journal of Immunology · doi:10.1002/eji.70009 · Cited by 8
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes
Maddaloni, E., Amendolara, R., Balena, A., Latino, A., Sessa, R. L., & Buzzetti, R. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2326036 · Cited by 7
Qiu, S., Zhou, G., Ke, J., Zhou, J., Zhang, H., Jin, Z., Xie, W., Huang, S., He, Z., Qin, H., et al. (2024) · Immunology · doi:10.1111/imm.13820 · Cited by 7
CD8+T cell exhaustion: the potential for treating autoimmune diseases
Xu, Y., Yi, X., Li, C., & Chen, J. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102600 · Cited by 6
Huang, H., Li, C., You, H., Zhang, Z., Lin, Q., Yang, J., Yu, H., Li, Z., Cui, G., Song, K., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218125 · Cited by 7
Self-citationWitkop, E. M., Diggins, K. E., WIEDEMAN, A. E., Serti, E., Nepom, G. T., Gersuk, V. H., Fuchs, B., Long, S. A., & Linsley, P. S. (2024) · Communications Biology · doi:10.1038/s42003-024-06456-3 · Cited by 5
Zhang, B., Zhao, X., Cao, J., Liu, Z., Wang, X., Li, R., Bo, H., Xu, K., & Guo, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1671482 · Cited by 5
Hua, T., Liu, D.-X., Zhang, X.-C., Li, S.-T., Wu, J.-L., Zhao, Q., & Chen, S.-B. (2024) · European journal of medical research · doi:10.1186/s40001-024-01948-8 · Cited by 5
Zhou, X., Gu, Y., Wang, H., Zhou, W., Zou, L., Li, S., Hua, C., & Gao, S. (2023) · Inflammation Research · doi:10.1007/s00011-023-01742-y · Cited by 5
T cell exhaustion dynamics in systemic autoimmune diseasePreprint
Turner, C. N., Sánchez‐Arcila, J. C., Huerta, N., Quiguoe, A. R., Jensen, K. D. C., & Hoyer, K. K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.23.573167 · Cited by 5
CAR-T cell therapy for solid tumors: HIF-1α as a potential enhancement strategy
Li, H., Xiong, J., Wang, C. H., Hu, L. B., Wang, Y. B., Ping, Q. R., Yang, M., Tan, J., Li, T., & Yang, Y. (2025) · Autoimmunity · doi:10.1080/08916934.2025.2579069 · Cited by 7
Lu, B., Zhang, Y., Wang, J., Yang, D., Liu, M., Ma, L., Yi, W., Liang, Y., Xu, Y., Fan, H., et al. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.07.005 · Cited by 4
Chen, M., Nie, Z., Huang, D., Gao, Y., Cao, H., Zheng, L., & Zhang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192428 · Cited by 4
Integrating Omics into Functional Biomarkers of Type 1 DiabetesPreprint
Long, S. A., & Linsley, P. S. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041602 · Cited by 7
Zhao, W., Luo, Q., Yuan, B., Duan, H., & Jiang, S. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2025.153 · Cited by 3
Balancing Intrinsic and Extrinsic Factors in CD8 + T Cell Therapy
Lee, D., & Lee, Y. (2026) · Immune Network · doi:10.4110/in.2026.26.e5 · Cited by 4
Hong, H., Shi, X., Ou, W., & Ou, P. (2024) · Biomedical Reports · doi:10.3892/br.2024.1751 · Cited by 3
Ni, W., Ren, L., Liao, L., Li, D., Luo, Z., Zhu, M., Liu, Y., Xing, H., Wang, Z., & Shao, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1378048 · Cited by 3
Learning the language of T cell receptors through large-scale screening
Moravec, Ž., Haanen, J. B. A. G., Schumacher, T. N., & Scheper, W. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.032 · Cited by 3
Tang, X., Miao, Y., Yang, L., Ha, W., Li, Z., & Mi, D. (2023) · IET Systems Biology · doi:10.1049/syb2.12072 · Cited by 2
A new prognostic risk model for acute myeloid leukemia patients based on telomere-related genes
Zhang, F., Du, H., Hu, C., & Song, Y. (2023) · Leukemia Research · doi:10.1016/j.leukres.2023.107404 · Cited by 2
Wang, G., Sun, Y., & Xu, Q. (2023) · Aging · doi:10.18632/aging.205157 · Cited by 2
Exploring the molecular landscape of lymphocyte activation gene-3: A literature review
Nie, J., Qin, X. Y., Tao, X., & Jin, H. (2024) · Medicine · doi:10.1097/md.0000000000039622 · Cited by 2
How do autoimmune CD4+ T cells handle exhaustion?
Fabri, A., & Walker, L. S. K. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.11.004 · Cited by 2
Zhang, Y., Zhou, Z., Rui, Y., Kong, F., Guo, Z., Zhao, G., Wang, J., Li, J., Zhao, F., Huang, H., et al. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04076-2 · Cited by 2
Zhou, X., Iakovliev, A., McGurnaghan, S. J., Erabadda, B., Hayward, C., McKeigue, P., Spiliopoulou, A., & Colhoun, H. M. (2025) · Diabetes · doi:10.2337/db25-0067 · Cited by 2
Nuclear Molecular Imaging for Evaluating T Cell Exhaustion
Zhou, H., Bao, G., Zhao, J., & Zhu, X. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00970 · Cited by 1
Zhao, M., Chen, L., Chen, Y., Yang, X., Feng, X., Yang, D., Zheng, X., & Liu, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094341 · Cited by 1
Khan, D. M. I. O., Kumar, R., Sriharsha, M., Mahavadi, S., & Kishore, A. (2025) · Cureus · doi:10.7759/cureus.97002 · Cited by 1
Immune landscape of the affected brain in Rasmussen encephalitis
Quinones-Valdez, G., Chang, J. W., Magaki, S., Vinters, H. V., Salamon, N., Wang, A. H., Fallah, A., & Owens, G. C. (2026) · Scientific Reports · doi:10.1038/s41598-026-51295-3 · Cited by 1
Upregulation of ADAM10 reinforces CD8 + T cells toward exhaustion in the TME
Abdalla, A. M. E., Miao, Y., Taha, Y. A., Meng, N., & Ouyang, C. (2026) · International Reviews of Immunology · doi:10.1080/08830185.2026.2669732 · Cited by 1
Extra-islet expression of islet antigen boosts T-cell exhaustion to prevent autoimmune diabetesPreprint
Selck, C., Jhala, G., George, D. J. D., Kwong, C.-T. J., Christensen, M. K., Pappas, E. G., Liu, X., Ge, T., Trivedi, P., Kallies, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.12.528226 · Cited by 1
T Cell Differentiation in Autoimmune Type 1 DiabetesPreprint
Schietinger, A., McBain, I. T., Hawley, K. M., & Miakicheva, S. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041592 · Cited by 2
A comprehensive reference of mouse CD8αβ T cell differentiation statesPreprint
Galletti, G., Globig, A.-M., Barreiro, O., Heim, T. A., Liu, S., Borys, S. M., Casey, O., Monell, A., Patravali, D., Scharping, N. E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.02.703365 · Cited by 3
Coincident epithelial signals restrain commensal-specific CD8αβ + T cells in the intestinePreprint
Olsen, T. M., Dufort, M. J., Verma, S., Makani, V. K. K., Cameron, B., Gralen, A. R., Johnson, A. J., Joglekar, A. V., Byrd, A. L., Lacy‐Hulbert, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.29.720676 · Cited by 1
Xia, Z., Lü, C., Pan, C., Li, J., Li, J., Mao, Y., Sun, L., & He, J. (2023) · Figshare · doi:10.6084/m9.figshare.23740700
Yuan, D. Y., McKeague, M. L., Raghu, V. K., Schoen, R. E., Finn, O. J., & Benos, P. V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.14.598031
Fonta, N., Pagé, N., Klimek, B., Piccinno, M., Liberto, G. D., Lemeille, S., Kreutzfeldt, M., Kastner, A. L., Ertuna, Y. I., Vincenti, I., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.09.602661
Gilmour, B. C., Visser, J. G., Köhn‐Luque, A., Borowicz, P., Lossius, A., & Spurkland, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.13.632739
Xia, Z.-A., Lu, C., Pan, C., Li, J., Li, J., Mao, Y., Sun, L., & He, J. (2023) · Figshare · doi:10.6084/m9.figshare.23740703
Hua, T., Liu, D.-X., Zhang, X.-C., Li, S.-T., Wu, J.-L., Zhao, Q., & Chen, S.-B. (2024) · Figshare · doi:10.6084/m9.figshare.26195835
Hua, T., Liu, D.-X., Zhang, X.-C., Li, S.-T., Wu, J.-L., Zhao, Q., & Chen, S.-B. (2024) · Figshare · doi:10.6084/m9.figshare.26195763
PI3Kδ promotes T cell effector differentiation and plasticity during chronic infectionPreprint
Pichler, A., Cannons, J. L., Golec, D. P., Reilley, J. M., Corral, D., Ansaldo, E., Xu, Q., Paul, S., Schaughency, P., Otaizo-Carrasquero, F. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.19.695585
DiLisio, J. E., Beard, K. S., Neef, T., Miller, S. D., Wenzlau, J. M., Nakayama, M., D’Antonio, M. A., Jamison, B. L., Nicholson, K., Baker, R. L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70878-2 · Cited by 1
Inhibitory receptor agonists: Emerging strategies in immune modulation
Adam, K. R., Suhail, A., Kuchroo, V. K., & Vignali, D. A. A. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20241217
Self-citationMukherjee, A. M. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00259-4 · Cited by 1
T cell exhaustion: next-generation target of autoimmune diseases?
Ouyang, Y., Luo, M., Li, K., Chen, K., Wen, Z., Zhou, Q., Shi, G., Xu, S., Luo, Z., & Yang, H. U. I. (2026) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiag052 · Cited by 1
Bissonnette, F. S.-D., Mediratta, K., Ho, N., Kirkby, M., Stalker, A., Muradia, G., Shrestha, A., Ardolino, M., Lee, S.-H., Burger, D. E., et al. (2026) · Molecular Therapy Oncology · doi:10.1016/j.omton.2026.201261
Metadata
- Authors
- Grebinoski, S., Zhang, Q., Cillo, A. R., Manne, S., Xiao, H., Brunazzi, E. A., Tabib, T., Cardello, C., Lian, C. G., Murphy, G. F., Lafyatis, R., Wherry, E. J., Das, J., Workman, C. J., & Vignali, D. A. A.
- Affiliations
- University of Pittsburgh (US)
- Boston Children's Hospital (US)
- University of Pennsylvania (US)
- Brigham and Women's Hospital (US)
- Parker Institute for Cancer Immunotherapy (US)
- Corresponding author
- Vignali, Dario A. A.
- ORCID
- Venue
- Nature Immunology
- Published
- 2022-05-26
- Volume
- 23
- Issue
- 6
- Pages
- 868-877
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC9179227
- OpenAlex
- W4281565387
- Cited by
- 107
- References
- 84
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 38 · 2023: 25 · 2022: 3
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK089125)
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI144422, AI108545, AI147638, AI089443, AI105343, AI117950, AI082630, AI112521, AI115712)
- U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA210944)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- CD8+ T cell exhaustion, LAG-3, type 1 diabetes, autoimmunity, pancreatic islets, T cell metabolism, T cell migration, inhibitory receptors, nonobese diabetic mouse, T cell fate
- MeSH terms
- Humans, Neoplasms, Phenotype, Autoimmunity, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review